Bile Acid Medicines Sales -- $41 million attributed to CHOLBAM and CTEXLI medicines supported by expanded CTX patient finding ...

Phase II Study in Fragile X Syndrome -- IND clearance received from FDA; first patient enrollment targeted by year-end with ...

Q4 2025 Earnings Call March 31, 2026 4:00 PM EDTCompany ParticipantsWilliam Li - President, CEO & ChairmanApoorv Dwivedi ...

Political scientist Jake Grumbach explains why Democrats are doing well in recent elections despite not moving to the center in the way that some pundits want.

Analyst/Investor Day March 31, 2026 12:00 PM EDTCompany ParticipantsAnoori Naughton - Vice President of Investor ...

Origin Materials, Inc. (NASDAQ:ORGN) Q4 2025 Earnings Call Transcript March 27, 2026 Origin Materials, Inc. misses on ...

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2025 Earnings Call Transcript March 30, 2026 PDS Biotechnology Corporation ...

Good afternoon, and thank you for joining us for our fourth quarter 2025 earnings call and business update. Joining me today ...

Hesai Group (NASDAQ:HSAI) Q4 2025 Earnings Call Transcript March 24, 2026 Hesai Group misses on earnings expectations.

We are now joined by vice chairman of Hendrick Motorsports, Jeff Gordon. We'll open it up for questions. Q. Were you concerned in the camp or this is part of the process of going through a new body?

Graphite Bio, Inc. (NASDAQ:GRPH) Q4 2025 Earnings Call Transcript March 24, 2026 Operator: Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics Year-end 2025 Financial Results ...

As a reminder, as we entered this fiscal year, we made a proactive and strategic decision to reinvest to improve the ...